Aethlon Medical, Inc.
(NASDAQ : AEMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ISRGIntuitive Surgical, Inc.
-0.87%516.782.4%$452.42m
MDTMedtronic PLC
-0.44%88.030.6%$375.13m
ABTAbbott Laboratories
-0.71%63.330.8%$332.30m
ABMDABIOMED, Inc.
-0.59%423.483.3%$308.23m
ALGNAlign Technology, Inc.
1.37%375.386.3%$287.28m
TMOThermo Fisher Scientific Inc.
0.38%216.891.0%$282.17m
BDXBecton, Dickinson and Company
0.03%247.051.1%$248.99m
BSXBoston Scientific Corporation
0.13%33.771.1%$192.51m
EWEdwards Lifesciences Corporation
1.55%152.611.2%$170.15m
BAXBaxter International Inc.
0.36%75.011.7%$169.83m
SYKStryker Corporation
0.86%174.341.3%$165.26m
COOCooper Companies, Inc.
0.26%248.632.2%$106.36m
WATWaters Corporation
-0.23%197.183.4%$102.73m
ZBHZimmer Biomet Holdings, Inc.
-0.53%111.651.7%$98.04m
IDXXIDEXX Laboratories, Inc.
2.19%248.143.7%$97.78m

Company Profile

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.